Results for tag: "Opioid Antagonist"

The Opioid Antagonist market is a subset of the Addiction Disorders Drugs market, which focuses on medications used to treat opioid addiction. Opioid Antagonists are drugs that block the effects of opioids, such as heroin, morphine, and codeine. These drugs are used to reduce cravings and withdrawal symptoms, and to prevent overdoses. They are also used to treat opioid-induced constipation. Common opioid antagonists include naltrexone, naloxone, and buprenorphine. Opioid Antagonists are typically prescribed by doctors and administered in a variety of ways, including oral tablets, injections, and implants. They are also available in generic forms, as well as brand-name products. Some companies in the Opioid Antagonist market include Reckitt Benckiser, Indivior, and Alkermes. Other companies include Mylan, Mallinckrodt, and Purdue Pharma. Show Less Read more